European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
Community Register of medicinal products
Community register of orphan medicinal products | GRANTED |
Product information |
Catumaxomab
| EU orphan designation number: | EU/3/06/414
|
| Active ingredient: | Catumaxomab |
| Indication: | Treatment of gastric cancer |
| Sponsor: | Fresenius Biotech GmbH
Am Haag 6-7, D-82166 Graefelfing, Deutschland |
Public summary of scientific opinion
European Commission procedures
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 07/11/2006 | Centralised Orphan - Designation | EMEA/OD/044/06 | (2006)5374 of 03/11/2006 |